Pharma: Clinic Roundup
Friday, June 22, 2012
Iroko Pharmaceuticals LLC, of Philadelphia, reported Phase III study results that showed patients treated with its submicron particle, lower-dose diclofenac experienced significant pain relief following surgery compared with placebo.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.